Devices › Device types
FDA product code NJL · class 3 · Unknown
Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing: medical device reports filed with FDA
26,046 reports carry this product code, 2004–2026; 30 brands with a page.
- 26,046
- reports with this product code
- 0.1% of all MAUDE reports
- 929
- reports, 12 months to August 2026
- 1,124 in the 12 months before
- 3.2%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code NJL is FDA's classification for "Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing" (unknown panel), a class 3 device. 26,046 medical device reports carry this product code, 0.1% of the MAUDE database, from May 2004 to August 2026.
929 reports arrived in the 12 months to August 2026, down 17% from 1,124 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (96.8%) and malfunction (3.2%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Depuy Ireland - 9616671 | 7,191 | 27.6% |
| Depuy Orthopaedics US | 5,745 | 22.1% |
| Depuy Ireland 9616671 | 2,551 | 9.8% |
| Depuy Orthopaedics | 2,005 | 7.7% |
| Depuy Orthopaedics 1818910 | 1,425 | 5.5% |
| Depuy Ireland | 1,173 | 4.5% |
| Depuy-Cork A Division Of Depuy Orthopaedics | 914 | 3.5% |
| 9616671 Depuy Ireland | 517 | 2% |
| Zimmer | 470 | 1.8% |
| Depuy Warsaw | 413 | 1.6% |
| Depuy-Raynham A Division Of Depuy Orthopaedics | 304 | 1.2% |
| 1219655 Depuy-Raynham A Div Of Depuy Orthopaedic | 270 | 1% |
| 1818910 Depuy Orthopaedics | 270 | 1% |
| Depuy Ireland Reg 9616671 | 269 | 1% |
| Depuy Raynham | 224 | 0.9% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 5,150 | 19.8% |
| Loss of or failure to bond | 4,794 | 18.4% |
| Implant, removal of | 1,828 | 7% |
| Naturally worn | 1,506 | 5.8% |
| Loose | 583 | 2.2% |
| Migration or expulsion of device | 499 | 1.9% |
| Loss of osseointegration | 445 | 1.7% |
| Migrationthe device moved from where it was placed | 415 | 1.6% |
| Component(s), worn | 357 | 1.4% |
| Loose or intermittent connection | 286 | 1.1% |
| Malposition of device | 264 | 1% |
| Unintended movement | 247 | 0.9% |
| Device dislodged or dislocated | 241 | 0.9% |
| Osseointegration problem | 234 | 0.9% |
| Fracturea broken bone | 230 | 0.9% |
| Breakthe device broke | 211 | 0.8% |
| Other (for use when an appropriate device code cannot be identified) | 207 | 0.8% |
| Noise, audible | 145 | 0.6% |
| Inadequacy of device shape and/or size | 135 | 0.5% |
| Explanted | 116 | 0.4% |
Questions about prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing reports
What is product code NJL?
FDA's classification code for "Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
26,046 reports through August 2026, 929 of them in the latest 12 months.
Which brands appear most often?
Mbt Cem Keel Tib Tray Sz3 (1,028), Mbt Cem Keel Tib Tray Sz4 (616), Mbt Cem Keel Tib Tray Sz2 5 (615), Attune Rp Tib Base Sz 5 Cem (603) and Attune Rp Tib Base Sz 4 Cem (593). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.